Waltham, MA, March 10,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, is launching an ongoing advisory
program that will monitor the effects of the novel coronavirus on
biopharmaceutical companies operations. The advisory is based on the feedback
from surveyed pharmaceutical companies in the TGaS network, a division of
Trinity.
Some of the immediate results show that 100 percent of biopharmaceutical
companies participating in the survey say they have travel restrictions in
place. Eleven out of 15 companies report that only essential travel is being
approved, five out of 15 are barring international travel and two of the 15
have a policy that employees are not allowed to travel to CDC level three
countries. Currently, only one of the 15 has limited vendor access to company
locations.
Sales reps are beginning to feel the impact of the virus
with nine of the 15 companies indicating that their sales force is beginning to
face access issues. Two of the companies surveyed have already made changes to
planned call activity.
“Biopharmaceutical companies are not the only ones making
immediate changes to their policies and operations. For example, some large
payers intend to waive co-pays related to testing for the coronavirus,” said
Gary McWalters, President of TGaS Advisors, a division of Trinity. “In some cases,
payers are requiring manufacturers to provide information regarding product
sourcing, safety stock levels and any concerns regarding continuity of supply.”
The ongoing advisory is available to all members of the TGaS
Life Sciences Network, which offers benchmarking and advisory services to
emerging, pre-commercial and large life sciences companies.
Media can request access to findings in the advisory by
contacting Liz Marshall, emarshall@trinitylifesciences.com.
About Trinity Life Sciences
Trinity
Life Sciences is a trusted strategic partner, providing evidence-based
solutions for the life sciences. With over 20 years of experience, Trinity is
committed to solving clients’ most challenging problems through exceptional
levels of service, powerful tools, and data-driven insights. Trinity’s range of
products and solutions includes industry-leading benchmarking solutions,
powered by TGaS Advisors. To learn more about how Trinity is elevating life
sciences and driving evidence to action, visit trinitylifesciences.com.
For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com